Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient Study-Reference-Cited by-同舟云学术

Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient Study

Published:2013-02 Issue:2 Volume:36 Page:189-196
ISSN:0161-8105
Container-title:Sleep
language:en
Short-container-title:

Author:

Roth Thomas,Krystal Andrew,Steinberg Frank J.,Singh Nikhilesh N.,Moline Margaret

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Clinical Neurology

Link

http://academic.oup.com/sleep/article-pdf/36/2/189/13668677/aasm.36.2.189.pdf

Reference12 articles.

1. What are the contributing factors for insomnia in the general population?;Ohayon;J Psychosom Res,2001

2. Using difficulty resuming sleep to define nocturnal awakenings;Ohayon;Sleep Med,2010

3. Behaviour of insomniacs and implication for their management;Estivill;Sleep Med Rev,2002

4. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose transmucosal zolpidem;Roth;Hum Psychopharmacol,2008

5. Accessed August 18, 2012 http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Treatment of Insomnia;Tasman’s Psychiatry;2024

2. Pharmacology;Atlas of Clinical Sleep Medicine;2024

3. Insomnia medications: History, characteristics, and guidelines for optimal use in clinical practice;Journal of Sleep Research;2023-11-08

4. 2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults – Brazilian Sleep Association;Sleep Science;2023-10

5. The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials;Drugs;2023-03-22